These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 458556)

  • 1. Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.
    Kramer WG; Kolibash AJ; Lewis RP; Bathala MS; Visconti JA; Reuning RH
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):47-61. PubMed ID: 458556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of digoxin in sheep: limitations of the use of biological half-life for interspecies extrapolation.
    Dix LP; Bai SA; Rogers RA; Anderson DL; Riviere JE
    Am J Vet Res; 1985 Feb; 46(2):470-2. PubMed ID: 3994115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic modeling of digoxin-induced bradycardia.
    Vetticaden SJ; Barr WH; Allison TB
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):89-107. PubMed ID: 2715933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.
    Jogestrand T; Sundqvist K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):89-95. PubMed ID: 7202476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study.
    Partanen J; Heikkilä J; Pellinen T; Nieminen MS
    Br J Clin Pharmacol; 1988 Mar; 25(3):331-40. PubMed ID: 3358896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.
    Reuning RH; Sams RA; Notari RE
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):127-41. PubMed ID: 4487163
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative pharmacodynamics of betamethyl digoxin and digoxin in man.
    Das GP; Talmers RN; Weissler AM
    Clin Pharmacol Ther; 1977 Sep; 22(3):280-5. PubMed ID: 891096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations in interpretation of digoxin adsorption using averaged pharmacological response intensities.
    Gustafson JH; Schoenwald RD; Benet LZ
    J Pharm Sci; 1976 Feb; 65(2):243-7. PubMed ID: 1255456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.
    Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of the serum digoxin concentration--response relationship to patient management.
    Kolibash AJ; Lewis RP; Bourne DW; Kramer WG; Reuning RH
    J Clin Pharmacol; 1989 Apr; 29(4):300-6. PubMed ID: 2723118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the steady-state volume of distribution for digoxin: a comparison of model-independent methods with a two-compartment model in healthy volunteers.
    De Vito JM; Crass RE; Blum RA; Pleasants RA; Schentag JJ
    Drug Intell Clin Pharm; 1985 Nov; 19(11):837-9. PubMed ID: 4064918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose kinetics of intravenous digoxin.
    Ochs HR; Greenblatt DJ; Bodem G
    Clin Pharmacol Ther; 1980 Sep; 28(3):340-5. PubMed ID: 7408393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of beta-methyldigoxin in healthy humans III: Pharmacodynamic correlations.
    Hinderling PH; Garrett ER
    J Pharm Sci; 1977 Mar; 66(3):326-9. PubMed ID: 851492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and elimination of digoxin in infants.
    Wettrell G
    Eur J Clin Pharmacol; 1977; 11(5):329-35. PubMed ID: 880972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.
    Rabkin SW; Grupp G
    Acta Cardiol; 1975; 30(5):343-51. PubMed ID: 1082700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of digoxin in the turkey and comparison with other species.
    Park E; Einzig S; Staley NA; Noren GR
    J Pharmacokinet Biopharm; 1981 Jun; 9(3):357-66. PubMed ID: 7288595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.
    Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R
    Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.